跳至主要内容
临床试验/NCT00743626
NCT00743626已完成不适用

Evaluation of the Role of Human Papillomavirus Testing and p16 Expression in the Management of Patients Undergoing Cervical Cancer Screening

University Health Network, Toronto2 个研究点 分布在 1 个国家目标入组 1,712 人开始时间: 2006年12月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
1,712
试验地点
2
主要终点
To provide cervical cancer screening (Pap smear, HPV test and/or p16 tests) to determine whether further intervention (colposcopy) is required

研究概览

简要总结

The principal hypothesis of this study is that HPV testing and/or p16 testing, either alone or in combination or associated with a Pap smear, will demonstrate greater specificity for clinically significant precancerous disease than will a Pap smear alone and that these tests will be of comparable or superior sensitivity than the Pap smear.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 18 years and older
  • Ability to speak and clearly understand English
  • Female patients

排除标准

  • No previous history of Cervical Cancer Treatment(LEEP,Laser,Cone etc.)
  • Women who have had Pap smears within the previous 10 months
  • Women under the age of
  • Women who are pregnant.
  • Inability to give informed consent in English

研究组 & 干预措施

1

Other

Healthy patients screened for cervical cancer

干预措施: Diagnostic cervical cancer screening tests (Pap smear, HPV and/or p16) (Other)

结局指标

主要结局

To provide cervical cancer screening (Pap smear, HPV test and/or p16 tests) to determine whether further intervention (colposcopy) is required

时间窗: 1st visit, 12 months, 18 months follow up

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验